Testosterone Therapy in diabetic and non-diabetic patients with Chronic Kidney Disease: growing interest and potentially new therapeutic implications
Top Italian Scientists Journal · 2026
DOI: 10.62684/cdpx9103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Top Italian Scientists Journal, 2026. Verfasst von Sandro La Vignera und 3 weiteren Autor:innen.
Abstract (Originalsprache)
This is a short editorial summarizing a highly relevant clinical problem from an epidemiological perspective i.e. the possible pathophysiological links between testosterone deficiency (hypogonadism) in males, a condition known as hypogonadism, and renal function in patients with chronic kidney disease. While these two conditions may share important pathophysiological links, in clinical practice they are mostly considered unrelated. Testosterone hormone replacement therapy (HT) may likely help reduce the progression of chronic kidney disease, although patient phenotyping and the recognition of potential diagnostic biases must be considered to avoid risks.
Zitieren
APA
Vignera, S. L., Granata, A., Condorelli, R. A., & Basile, L. (2026). Testosterone Therapy in diabetic and non-diabetic patients with Chronic Kidney Disease: growing interest and potentially new therapeutic implications. Top Italian Scientists Journal. https://doi.org/10.62684/cdpx9103
Vancouver
Vignera SL, Granata A, Condorelli RA, Basile L. Testosterone Therapy in diabetic and non-diabetic patients with Chronic Kidney Disease: growing interest and potentially new therapeutic implications. Top Italian Scientists Journal. 2026. doi:10.62684/cdpx9103
BibTeX
@article{Vignera2026,
author = {Vignera, Sandro La and Granata, Antonio and Condorelli, Rosita A. and Basile, Livia},
title = {Testosterone Therapy in diabetic and non-diabetic patients with Chronic Kidney Disease: growing interest and potentially new therapeutic implications},
journal = {Top Italian Scientists Journal},
year = {2026},
doi = {10.62684/cdpx9103}
}
EUVIMED